Apple's quarterly results and forecast beat modest expectations on Thursday, as the iPhone maker unveiled a record share buyback program, sending its stock up 6% in extended trade. Apple increased its cash dividend by 4% and authorized an additional program to buy back $110 billion of stock. The buyback is the largest in the company's history.
FDA refuses Moderna mRNA flu vaccine application, citing inadequate study design that could delay stronger protection shot, as Stéphane Bancel says decision contradicts prior FDA guidance....